KREBS BIOCHEMICALS & INDUSTRIES
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr |
Equity - Authorised | ₹23 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
Equity - Issued | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr |
Equity Paid Up | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | ₹4.17 Cr | ₹7.65 Cr |
Total Reserves | ₹-141 Cr | ₹-121 Cr | ₹-97 Cr | ₹-67 Cr | ₹-51 Cr |
Securities Premium | ₹118 Cr | ₹118 Cr | ₹118 Cr | ₹103 Cr | ₹91 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹-270 Cr | ₹-250 Cr | ₹-226 Cr | ₹-181 Cr | ₹-153 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Reserve excluding Revaluation Reserve | ₹-141 Cr | ₹-121 Cr | ₹-97 Cr | ₹-67 Cr | ₹-51 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹-119 Cr | ₹-99 Cr | ₹-75 Cr | ₹-43 Cr | ₹-25 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | ₹184 Cr | ₹173 Cr | ₹133 Cr | ₹101 Cr | ₹66 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | ₹0.25 Cr | ₹0.38 Cr | ₹0.56 Cr | ₹1.11 Cr | ₹1.74 Cr |
Loans - Others | - | - | ₹0.55 Cr | ₹3.55 Cr | ₹2.00 Cr |
Other Unsecured Loan | ₹183 Cr | ₹173 Cr | ₹132 Cr | ₹96 Cr | ₹62 Cr |
Deferred Tax Assets / Liabilities | - | - | - | - | - |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | - | - | - | - | - |
Other Long Term Liabilities | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr |
Long Term Trade Payables | ₹4.01 Cr | ₹4.50 Cr | ₹6.27 Cr | ₹5.65 Cr | ₹2.69 Cr |
Long Term Provisions | ₹3.05 Cr | ₹2.60 Cr | ₹2.63 Cr | ₹2.56 Cr | ₹2.46 Cr |
Total Non-Current Liabilities | ₹236 Cr | ₹225 Cr | ₹187 Cr | ₹154 Cr | ₹116 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr |
Sundry Creditors | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹32 Cr | ₹23 Cr | ₹29 Cr | ₹16 Cr | ₹18 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹17 Cr | ₹12 Cr | - | ₹5.51 Cr | ₹5.90 Cr |
Interest Accrued But Not Due | ₹9.54 Cr | ₹6.06 Cr | ₹8.18 Cr | ₹3.99 Cr | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹5.49 Cr | ₹4.70 Cr | ₹21 Cr | ₹6.43 Cr | ₹13 Cr |
Short Term Borrowings | ₹9.93 Cr | ₹9.99 Cr | ₹9.99 Cr | ₹10.00 Cr | - |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹9.93 Cr | ₹9.99 Cr | ₹9.99 Cr | ₹10.00 Cr | - |
Short Term Provisions | ₹1.06 Cr | ₹1.26 Cr | ₹1.17 Cr | ₹1.49 Cr | ₹1.99 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.06 Cr | ₹1.26 Cr | ₹1.17 Cr | ₹1.49 Cr | ₹1.99 Cr |
Total Current Liabilities | ₹62 Cr | ₹49 Cr | ₹78 Cr | ₹48 Cr | ₹43 Cr |
Total Liabilities | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr | ₹134 Cr |
ASSETS | |||||
Gross Block | ₹312 Cr | ₹303 Cr | ₹288 Cr | ₹261 Cr | ₹243 Cr |
Less: Accumulated Depreciation | ₹163 Cr | ₹156 Cr | ₹149 Cr | ₹143 Cr | ₹138 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹150 Cr | ₹147 Cr | ₹139 Cr | ₹118 Cr | ₹105 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.16 Cr | ₹2.24 Cr | ₹6.53 Cr | ₹10 Cr | ₹2.35 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹8.77 Cr | ₹7.52 Cr | ₹7.23 Cr | ₹7.71 Cr | ₹5.24 Cr |
Other Non Current Assets | - | - | - | ₹0.23 Cr | ₹0.22 Cr |
Total Non-Current Assets | ₹161 Cr | ₹159 Cr | ₹154 Cr | ₹138 Cr | ₹115 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹9.80 Cr | ₹12 Cr | ₹26 Cr | ₹17 Cr | ₹15 Cr |
Raw Materials | ₹2.67 Cr | ₹3.36 Cr | ₹10.00 Cr | ₹8.36 Cr | ₹6.52 Cr |
Work-in Progress | ₹5.12 Cr | ₹6.39 Cr | ₹12 Cr | ₹6.64 Cr | ₹6.88 Cr |
Finished Goods | ₹1.51 Cr | ₹1.31 Cr | ₹1.65 Cr | ₹1.39 Cr | ₹1.49 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹0.50 Cr | ₹0.10 Cr | ₹0.61 Cr | ₹0.21 Cr | ₹0.12 Cr |
Other Inventory | - | ₹0.79 Cr | ₹1.39 Cr | - | - |
Sundry Debtors | ₹1.90 Cr | ₹0.53 Cr | ₹0.88 Cr | ₹0.30 Cr | ₹0.20 Cr |
Debtors more than Six months | - | - | - | ₹0.00 Cr | ₹0.08 Cr |
Debtors Others | ₹1.90 Cr | ₹0.53 Cr | ₹0.88 Cr | ₹0.30 Cr | ₹0.17 Cr |
Cash and Bank | ₹0.14 Cr | ₹0.09 Cr | ₹0.10 Cr | ₹0.71 Cr | ₹0.17 Cr |
Cash in hand | ₹0.00 Cr | ₹0.00 Cr | - | ₹0.00 Cr | ₹0.02 Cr |
Balances at Bank | ₹0.14 Cr | ₹0.08 Cr | ₹0.10 Cr | ₹0.71 Cr | ₹0.16 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.54 Cr | ₹0.65 Cr | ₹0.59 Cr | ₹0.47 Cr | ₹0.31 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.17 Cr | ₹0.14 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.07 Cr |
Prepaid Expenses | ₹0.38 Cr | ₹0.52 Cr | ₹0.49 Cr | ₹0.40 Cr | ₹0.24 Cr |
Other current_assets | - | - | - | - | - |
Short Term Loans and Advances | ₹5.06 Cr | ₹2.85 Cr | ₹8.36 Cr | ₹3.34 Cr | ₹3.18 Cr |
Advances recoverable in cash or in kind | ₹3.29 Cr | ₹0.56 Cr | ₹0.42 Cr | ₹0.58 Cr | ₹0.40 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹1.77 Cr | ₹2.29 Cr | ₹7.95 Cr | ₹2.76 Cr | ₹2.77 Cr |
Total Current Assets | ₹17 Cr | ₹16 Cr | ₹35 Cr | ₹21 Cr | ₹19 Cr |
Net Current Assets (Including Current Investments) | ₹-44 Cr | ₹-33 Cr | ₹-43 Cr | ₹-27 Cr | ₹-24 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr | ₹134 Cr |
Contingent Liabilities | ₹9.94 Cr | ₹5.63 Cr | ₹5.55 Cr | ₹5.49 Cr | ₹4.70 Cr |
Total Debt | ₹194 Cr | ₹183 Cr | ₹143 Cr | ₹111 Cr | ₹66 Cr |
Book Value | -55.29 | -46.13 | -34.83 | -23.91 | -18.14 |
Adjusted Book Value | -55.29 | -46.13 | -34.83 | -23.91 | -18.14 |
Compare Balance Sheet of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹177.3 Cr | -7.9% | -16.9% | 9.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,259.0 Cr | 0.5% | -3.4% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,917.0 Cr | -2.2% | 0.3% | 58.8% | Stock Analytics | |
CIPLA | ₹119,705.0 Cr | 2.2% | 3.9% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,953.9 Cr | -1.5% | -7% | -5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,889.3 Cr | -2.3% | -7.4% | 3.7% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | -7.9% |
-16.9% |
9.9% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses